- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03194919
Negotiating a Quit Date or Not in Online Interventions
The Effect of Negotiating a Quit Date on Attempting to Quit Smoking
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Web- and mobile phone health behavior change interventions, including smoking cessation programs, offer great promise, but little is known about how such interventions should be designed to increase their efficacy
The primary purpose of the current study is to test the effect of providing users of automated web-based smoking cessation interventions with the option of negotiating and re-negotiating the quit date.
The investigators propose a 2-arm RCT with 1500 adult study participants that all receive a best practices web-based smoking cessation program designed for use on smart phones (web-app). The intervention includes a ten day/session preparation phase (participants continue smoking) as well as a four week post-cessation follow-up phase (14 sessions). The post-cessation phase will only be given to participants that report an initial quit attempt. Participants will be randomized to two versions of the intervention: 1) A version that does not provide participants with the option of negotiating the quit day (the preparation phase is fixed to ten days/sessions); or 2) a version that provides the participants with the option of negotiating/re-negotiate the quit day on three occasions. The three occasions are on the first day/session of the intervention, on the fourth day/session of the intervention and on the eleventh day/session of the intervention. The primary outcome is making a quit attempt.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Håvar Brendryen, PhD
- Phone Number: +47 99521714
- Email: brendryen@gmail.com
Study Locations
-
-
-
Prague, Czechia
- Not yet recruiting
- Department of Addictology, 1st Faculty of Medicine, Charles University
-
Contact:
- Roman Gabrhelík, PhD
- Email: gabrhelik@adiktologie.cz
-
-
-
-
-
Oslo, Norway
- Recruiting
- The Norwegian Centre for Addiction Research
-
Contact:
- Håvar Brendryen, PhD
- Phone Number: +47 99521714
- Email: brendryen@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 year or older
- being a current smoker
- determined to or considering to quit smoking
- provide valid e-mail address
- provide valid norwegian cell phone number
- complete a baseline questionnaire
- start using the intervention (pushing the next page button one time or more on the first session provided
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Negotiating quit date
Endre: a digital smoking cessation counsellor
|
A comprehensive 25-session intervention delivered by web, e-mail and SMS-text messages.
Sessions are released one each day for 18 days, and then every second day for 14 days.
Intervention content is tailored based on user input and individual usage pattern.
The intervention is described in detail in Holter, Johansen & Brendryen (2016).
How a fully automated eHealth program simulates three therapeutic processes: A case study.
Journal of Medical Internet Research 18 (6).
|
Active Comparator: Preset quit date
Endre: a digital smoking cessation counsellor
|
A comprehensive 25-session intervention delivered by web, e-mail and SMS-text messages.
Sessions are released one each day for 18 days, and then every second day for 14 days.
Intervention content is tailored based on user input and individual usage pattern.
The intervention is described in detail in Holter, Johansen & Brendryen (2016).
How a fully automated eHealth program simulates three therapeutic processes: A case study.
Journal of Medical Internet Research 18 (6).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quit attempt
Time Frame: Within 6 weeks after starting the first session of the intervention
|
User report a quit attempt
|
Within 6 weeks after starting the first session of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of sessions in preparation phase completed
Time Frame: Within 6 weeks after starting the first session of the intervention
|
Ten sessions are available
|
Within 6 weeks after starting the first session of the intervention
|
Number of sessions in preparation phase started
Time Frame: Within 6 weeks after starting the first session of the intervention
|
Ten sessions are available
|
Within 6 weeks after starting the first session of the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Håvar Brendryen, PhD, University of Oslo
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NFR 228158/H10-B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nicotine Dependence, Cigarettes
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruiting
-
Duke UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence, CigarettesUnited States
-
Milton S. Hershey Medical CenterTerminatedNicotine Dependence, CigarettesUnited States
-
Semmelweis UniversityCompleted
-
University of VermontNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence, CigarettesUnited States
-
Freedom Laser, Inc.NST Consultants, Inc.Completed
-
University of VermontNational Institute of General Medical Sciences (NIGMS)CompletedNicotine Dependence, CigarettesUnited States
-
Milton S. Hershey Medical CenterCompleted
-
Brown UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence, Cigarettes, UncomplicatedUnited States
-
Duke UniversityNational Institute on Drug Abuse (NIDA)RecruitingNicotine Dependence, Cigarettes | Adverse Childhood ExperiencesUnited States
Clinical Trials on Endre: a digital smoking cessation counsellor
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruiting
-
Portsmouth Hospitals NHS TrustCompleted
-
Peking Union Medical College HospitalRun Shaw Hospital, Zhejiang University School of Medicine; Hangzhou Medisol...Not yet recruitingSecondhand Smoking | Passive Smoking | Tobacco Smoke PollutionChina
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminated
-
The University of Hong KongNot yet recruiting
-
Mayo ClinicCompletedSmoking CessationUnited States
-
Loma Linda UniversityNot yet recruitingSmoking Cessation
-
Massachusetts General HospitalTerminatedSmoking Cessation | Attention Deficit/Hyperactivity Disorder
-
Qatar UniversityHamad Medical CorporationCompleted